Yeon-a Park

Title: Yeon-a Park: Innovator in Cancer Diagnostics

Introduction

Yeon-a Park is a prominent inventor based in Yongin, South Korea. He has made significant contributions to the field of cancer diagnostics, holding a total of 4 patents. His work focuses on developing innovative methods for diagnosing various types of cancer, particularly colon and breast cancer.

Latest Patents

Yeon-a Park's latest patents include groundbreaking inventions such as a polynucleotide associated with colon cancer, which comprises a single nucleotide polymorphism, a microarray, and a diagnostic kit for diagnosing colon cancer using the polynucleotide. This invention provides a polynucleotide that includes at least 10 contiguous nucleotides of a nucleotide sequence selected from a specific group, including a nucleotide at position 101 of the nucleotide sequence. Additionally, he has developed a polynucleotide associated with breast cancer, which also includes a single nucleotide polymorphism, a microarray, and a diagnostic kit for diagnosing breast cancer. This polynucleotide is designed for diagnosis or treatment of breast cancer and includes at least 10 contiguous nucleotides of a nucleotide sequence from a defined group, comprising a nucleotide at position 101.

Career Highlights

Yeon-a Park is currently employed at Samsung Electronics Co., Ltd., where he continues to innovate in the field of medical diagnostics. His work has been instrumental in advancing the understanding and detection of cancer, contributing to improved patient outcomes.

Collaborations

Some of his notable coworkers include Yeon-Su Lee and Ok-kyoung Son, who collaborate with him on various projects related to cancer diagnostics.

Conclusion

Yeon-a Park's contributions to cancer diagnostics through his innovative patents highlight his role as a leading inventor in the field. His work not only advances scientific knowledge but also has the potential to significantly impact patient care and treatment options.